First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 14, 2024

Meridian Bioscience Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Meridian Bioscience Inc
Gross Profit Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Gross Profit
$188.4m
CAGR 3-Years
17%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Gross Profit
$2.4B
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
9%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Gross Profit
$2.1B
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
3%
Align Technology Inc
NASDAQ:ALGN
Gross Profit
$2.7B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
18%
Lantheus Holdings Inc
NASDAQ:LNTH
Gross Profit
$874.3m
CAGR 3-Years
82%
CAGR 5-Years
38%
CAGR 10-Years
26%

See Also

What is Meridian Bioscience Inc's Gross Profit?
Gross Profit
188.4m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Gross Profit amounts to 188.4m USD.

What is Meridian Bioscience Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
9%

Over the last year, the Gross Profit growth was -6%. The average annual Gross Profit growth rates for Meridian Bioscience Inc have been 17% over the past three years , 9% over the past five years .